World Of Taxonomy
C181790Level 4

Gemcitabine/Margetuximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of gemcitabine and margetuximab that can be used for the treatment of recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive breast cancer.

**Synonyms:** - Gemcitabine and Margetuximab - Gemcitabine-Margetuximab - Gemcitabine-Margetuximab Regimen - Gemcitabine/Margetuximab - Gemcitabine/Margetuximab-cmkb Regimen - Margenza/Gemzar - Margetuximab Plus Gemcitabine - Margetuximab-Gemcitabine - Margetuximab/Gemcitabine - Margetuximab/Gemcitabine Regimen

GET/api/v1/systems/nci_thesaurus/nodes/C181790
Official DownloadCC BY 4.0Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.